(Q40079884)

17 September 2017

1 reference

title

Thalidomide therapy for inflammatory dermatoses (English)

1 reference

17 September 2017

Thalidomide Therapy for Inflammatory Dermatoses (English)

1 reference

https://api.crossref.org/works/10.1111/J.1365-4362.1984.TB05696.X

4 August 2023

0 references

1 reference

https://api.crossref.org/works/10.1111/J.1365-4362.1984.TB05696.X

4 August 2023

author name string

E. Grosshans

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6097551

4 August 2023

G. Illy

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6097551

4 August 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6097551

4 August 2023

publication date

1 November 1984

1 reference

full work available at URL

17 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-4362.1984.tb05696.x

1 reference

https://api.crossref.org/works/10.1111/J.1365-4362.1984.TB05696.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-4362.1984.tb05696.x/fullpdf

4 August 2023

1 reference

https://api.crossref.org/works/10.1111/J.1365-4362.1984.TB05696.X

International Journal of Dermatology

4 August 2023

published in

1 reference

17 September 2017

23

1 reference

17 September 2017

598-602

1 reference

17 September 2017

9

1 reference

The thalidomide disaster briefly revisited

17 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1984.TB05696.X

Thalidomide for autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1984.TB05696.X

Thalidomide in actinic prurigo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1984.TB05696.X

Thalidomide in Rabbit Semen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1984.TB05696.X

THALIDOMIDE IN THE TREATMENT OF LEPRA REACTIONS

21 January 2018

5

1 reference

https://api.crossref.org/works/10.1111/J.1365-4362.1984.TB05696.X

Thalidomide in the treatment of actinic prurigo

4 August 2023

7

1 reference

https://api.crossref.org/works/10.1111/J.1365-4362.1984.TB05696.X

Polymorphous light eruption: Treatment with thalidomide

4 August 2023

13

1 reference

https://api.crossref.org/works/10.1111/J.1365-4362.1984.TB05696.X

Actinic prurigo (Hutchinson's summer prurigo)

4 August 2023

15

1 reference

https://api.crossref.org/works/10.1111/J.1365-4362.1984.TB05696.X

Treatment of prurigo nodularis with thalidomide

4 August 2023

18

1 reference

https://api.crossref.org/works/10.1111/J.1365-4362.1984.TB05696.X

Archives for dermatological research = Archiv fur dermatologische Forschung

4 August 2023

24

270

229

Knop J

1981

1 reference

https://api.crossref.org/works/10.1111/J.1365-4362.1984.TB05696.X

Thalidomide treatment of subacute cutaneous lupus erythematosus

4 August 2023

28

1 reference

https://api.crossref.org/works/10.1111/J.1365-4362.1984.TB05696.X

Treatment of ulcerative colitis with thalidomide

4 August 2023

36

1 reference

https://api.crossref.org/works/10.1111/J.1365-4362.1984.TB05696.X

Thalidomide in Weber-Christian disease

4 August 2023

37

1 reference

https://api.crossref.org/works/10.1111/J.1365-4362.1984.TB05696.X

Thalidomide: use and possible mode of action in reactional lepromatous leprosy and in various other conditions

4 August 2023

43

1 reference

https://api.crossref.org/works/10.1111/J.1365-4362.1984.TB05696.X

Inhibition of PMN leukocytes chemotaxis by thalidomide

4 August 2023

47

1 reference

https://api.crossref.org/works/10.1111/J.1365-4362.1984.TB05696.X

Inhibition of de novo IgM antibody synthesis by thalidomide as a relevant mechanism of action in leprosy

4 August 2023

48

1 reference

https://api.crossref.org/works/10.1111/J.1365-4362.1984.TB05696.X

Effects of thalidomide on the generation of oxygen intermediates by zymosan-stimulated normal polymorphonuclear leukocytes

4 August 2023

50

1 reference

https://api.crossref.org/works/10.1111/J.1365-4362.1984.TB05696.X

[Synthesis and teratogenic activity of some thalidomide analogous indane-1,3-diones (author's transl)]

4 August 2023

51

1 reference

https://api.crossref.org/works/10.1111/J.1365-4362.1984.TB05696.X

Teratogenic activity of a hydrolytic thalidomide metabolite in mice

4 August 2023

52

1 reference

https://api.crossref.org/works/10.1111/J.1365-4362.1984.TB05696.X

Study with nine thalidomide derivatives in the lepra reaction

4 August 2023

54

1 reference

https://api.crossref.org/works/10.1111/J.1365-4362.1984.TB05696.X

The saga of thalidomide. Neuropathy to embryopathy, with case reports of congenital anomalies

4 August 2023

58

1 reference

https://api.crossref.org/works/10.1111/J.1365-4362.1984.TB05696.X

Thalidomide neuropathy: a clinical electrophysiological, and histological follow-up study

4 August 2023

59

1 reference

https://api.crossref.org/works/10.1111/J.1365-4362.1984.TB05696.X

Unmyelinated nerve fibers in senile nerves and in late thalidomide neuropathy: a quantitative electron microscopic study (author's transl)

4 August 2023

61

1 reference

https://api.crossref.org/works/10.1111/J.1365-4362.1984.TB05696.X

4 August 2023

Identifiers

1 reference

17 September 2017

1 reference